We are live on ! Find out more
SONN

Sonnet BioTherapeutics
SONN

Delisted

SONN was delisted on the 2nd of December, 2025.

Back to rankings

1 hedge funds and large institutions have $1.57M invested in Sonnet BioTherapeutics in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

17% less capital invested

Capital invested by funds: $1.9M → $1.57M (-$327K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$227K
2
UBS Group
UBS Group
Switzerland
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
TDC
1
Thompson Davis & Co
Virginia
$381K – – –
Bank of America
2
Bank of America
North Carolina
$253K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$218K – – –
IC
4
Intersect Capital
California
$124K – – –
BIT
5
BlackRock Institutional Trust
California
$101K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$92K – – –
Morgan Stanley
7
Morgan Stanley
New York
$88K – – –
EVC
8
Eidelman Virant Capital
Missouri
$84K – – –
GHAM
9
Gilman Hill Asset Management
Connecticut
$60K – – –
CDH
10
Charles D. Hyman
$44K – – –
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$24K – – –
CL
12
CSS LLC
Illinois
$22K – – –
Goldman Sachs
13
Goldman Sachs
New York
$19K – – –
Northern Trust
14
Northern Trust
Illinois
$18K – – –
TSS
15
Two Sigma Securities
New York
$16K – – –
VKH
16
Virtu KCG Holdings
New York
$12K – – –
BFA
17
BlackRock Fund Advisors
California
$4K – – –
BIM
18
BlackRock Investment Management
Delaware
$3K – – –
CG
19
Cutler Group
California
$3K – – –
IA
20
IFP Advisors
Florida
$2K – – –
Millennium Management
21
Millennium Management
New York
– -$227K – –
UBS Group
22
UBS Group
Switzerland
– -$1K – –

SONN Hedge Fund Activity: Q4 2015 in Review

1 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sonnet BioTherapeutics (SONN) for Q4 2015, worth a combined $1.57M — down 17% from $1.9M a quarter earlier.

Fund positioning in SONN was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Millennium Management, cutting an estimated $227K.

  • 1 institutional investor held Sonnet BioTherapeutics (SONN) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $1.57M of Sonnet BioTherapeutics stock for Q4 2015, down 17% quarter-over-quarter.
  • 0 funds opened new Sonnet BioTherapeutics positions in Q4 2015 and 0 closed out.
  • The largest Sonnet BioTherapeutics seller in Q4 2015 was Millennium Management, an estimated $227K sold.

Based on aggregated 13F filings for Q4 2015.